Lipopolysaccharides, but not Angiotensin ll, lnduces Direct Pro‐lnflammatory Effects in Cultured Mouse Arteries and Human Endothelial and Vascular Smooth Muscle Cells

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Lipopolysaccharides, but not Angiotensin ll, lnduces Direct Pro‐lnflammatory Effects in Cultured Mouse Arteries and Human Endothelial and Vascular Smooth Muscle Cells. / Outzen, Emilie M; Zaki, Marina; Mehryar, Rahila; Abdolalizadeh, Bahareh; Sajid, Waseem; Boonen, Harrie C M; Sams, Anette; Sheykhzade, Majid.

In: Basic & Clinical Pharmacology & Toxicology, Vol. 120, No. 4, 04.2017, p. 335-347.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Outzen, EM, Zaki, M, Mehryar, R, Abdolalizadeh, B, Sajid, W, Boonen, HCM, Sams, A & Sheykhzade, M 2017, 'Lipopolysaccharides, but not Angiotensin ll, lnduces Direct Pro‐lnflammatory Effects in Cultured Mouse Arteries and Human Endothelial and Vascular Smooth Muscle Cells', Basic & Clinical Pharmacology & Toxicology, vol. 120, no. 4, pp. 335-347. https://doi.org/10.1111/bcpt.12697

APA

Outzen, E. M., Zaki, M., Mehryar, R., Abdolalizadeh, B., Sajid, W., Boonen, H. C. M., ... Sheykhzade, M. (2017). Lipopolysaccharides, but not Angiotensin ll, lnduces Direct Pro‐lnflammatory Effects in Cultured Mouse Arteries and Human Endothelial and Vascular Smooth Muscle Cells. Basic & Clinical Pharmacology & Toxicology, 120(4), 335-347. https://doi.org/10.1111/bcpt.12697

Vancouver

Outzen EM, Zaki M, Mehryar R, Abdolalizadeh B, Sajid W, Boonen HCM et al. Lipopolysaccharides, but not Angiotensin ll, lnduces Direct Pro‐lnflammatory Effects in Cultured Mouse Arteries and Human Endothelial and Vascular Smooth Muscle Cells. Basic & Clinical Pharmacology & Toxicology. 2017 Apr;120(4):335-347. https://doi.org/10.1111/bcpt.12697

Author

Outzen, Emilie M ; Zaki, Marina ; Mehryar, Rahila ; Abdolalizadeh, Bahareh ; Sajid, Waseem ; Boonen, Harrie C M ; Sams, Anette ; Sheykhzade, Majid. / Lipopolysaccharides, but not Angiotensin ll, lnduces Direct Pro‐lnflammatory Effects in Cultured Mouse Arteries and Human Endothelial and Vascular Smooth Muscle Cells. In: Basic & Clinical Pharmacology & Toxicology. 2017 ; Vol. 120, No. 4. pp. 335-347.

Bibtex

@article{1307ed21c0424ad29fa8371738adc611,
title = "Lipopolysaccharides, but not Angiotensin ll, lnduces Direct Pro‐lnflammatory Effects in Cultured Mouse Arteries and Human Endothelial and Vascular Smooth Muscle Cells",
abstract = "Angiotensin II (Ang II) might induce pro-inflammatory effects directly on the vascular wall independently of its hemodynamic effects. The aim of our study was to investigate the putative direct pro-inflammatory and vasomotor effects of Ang II and compare to those of LPS in mouse isolated mesenteric resistance-sized arteries (MRA) supported by experiments in cultured human primary endothelial and vascular smooth muscle cells. Results showed that 24-hr organ culture of mouse MRA with 10 nM Ang II had, unlike 100 ng/mL LPS, no effects on IL-6 or MCP-1 secretion, VCAM1 mRNA expression or endothelial function, while Ang II significantly decreased maximal vasomotor responses to phenylephrine. In support, 24-hr organ culture of mouse MRA significantly suppressed Agtr1a mRNA and augmented Tlr4 mRNA along with attenuated vasomotor responses to Ang II. Moreover, contrary to LPS and TNFα, Ang II and [Sar1]-Ang II had no concentration- or time-dependent effects on IL-6 and MCP-1 secretion in human umbilical vein endothelial cells (HUVEC) and human aortic smooth muscle cells (HASMC). AGTR1 or AGTR2 mRNA expression were undetectable in HUVEC, whereas HASMC expressed only AGTR1 mRNA. In summary, contrary to previous studies and the observed effects of LPS, we could not demonstrate direct vascular pro-inflammatory effects of Ang II ex vivo or in vitro. As indicated by our results, down-regulation or desensitization of AT1 R during culture may explain our findings. This article is protected by copyright. All rights reserved.",
author = "Outzen, {Emilie M} and Marina Zaki and Rahila Mehryar and Bahareh Abdolalizadeh and Waseem Sajid and Boonen, {Harrie C M} and Anette Sams and Majid Sheykhzade",
note = "This article is protected by copyright. All rights reserved.",
year = "2017",
month = "4",
doi = "10.1111/bcpt.12697",
language = "English",
volume = "120",
pages = "335--347",
journal = "Basic & Clinical Pharmacology & Toxicology",
issn = "1742-7835",
publisher = "Wiley-Blackwell",
number = "4",

}

RIS

TY - JOUR

T1 - Lipopolysaccharides, but not Angiotensin ll, lnduces Direct Pro‐lnflammatory Effects in Cultured Mouse Arteries and Human Endothelial and Vascular Smooth Muscle Cells

AU - Outzen, Emilie M

AU - Zaki, Marina

AU - Mehryar, Rahila

AU - Abdolalizadeh, Bahareh

AU - Sajid, Waseem

AU - Boonen, Harrie C M

AU - Sams, Anette

AU - Sheykhzade, Majid

N1 - This article is protected by copyright. All rights reserved.

PY - 2017/4

Y1 - 2017/4

N2 - Angiotensin II (Ang II) might induce pro-inflammatory effects directly on the vascular wall independently of its hemodynamic effects. The aim of our study was to investigate the putative direct pro-inflammatory and vasomotor effects of Ang II and compare to those of LPS in mouse isolated mesenteric resistance-sized arteries (MRA) supported by experiments in cultured human primary endothelial and vascular smooth muscle cells. Results showed that 24-hr organ culture of mouse MRA with 10 nM Ang II had, unlike 100 ng/mL LPS, no effects on IL-6 or MCP-1 secretion, VCAM1 mRNA expression or endothelial function, while Ang II significantly decreased maximal vasomotor responses to phenylephrine. In support, 24-hr organ culture of mouse MRA significantly suppressed Agtr1a mRNA and augmented Tlr4 mRNA along with attenuated vasomotor responses to Ang II. Moreover, contrary to LPS and TNFα, Ang II and [Sar1]-Ang II had no concentration- or time-dependent effects on IL-6 and MCP-1 secretion in human umbilical vein endothelial cells (HUVEC) and human aortic smooth muscle cells (HASMC). AGTR1 or AGTR2 mRNA expression were undetectable in HUVEC, whereas HASMC expressed only AGTR1 mRNA. In summary, contrary to previous studies and the observed effects of LPS, we could not demonstrate direct vascular pro-inflammatory effects of Ang II ex vivo or in vitro. As indicated by our results, down-regulation or desensitization of AT1 R during culture may explain our findings. This article is protected by copyright. All rights reserved.

AB - Angiotensin II (Ang II) might induce pro-inflammatory effects directly on the vascular wall independently of its hemodynamic effects. The aim of our study was to investigate the putative direct pro-inflammatory and vasomotor effects of Ang II and compare to those of LPS in mouse isolated mesenteric resistance-sized arteries (MRA) supported by experiments in cultured human primary endothelial and vascular smooth muscle cells. Results showed that 24-hr organ culture of mouse MRA with 10 nM Ang II had, unlike 100 ng/mL LPS, no effects on IL-6 or MCP-1 secretion, VCAM1 mRNA expression or endothelial function, while Ang II significantly decreased maximal vasomotor responses to phenylephrine. In support, 24-hr organ culture of mouse MRA significantly suppressed Agtr1a mRNA and augmented Tlr4 mRNA along with attenuated vasomotor responses to Ang II. Moreover, contrary to LPS and TNFα, Ang II and [Sar1]-Ang II had no concentration- or time-dependent effects on IL-6 and MCP-1 secretion in human umbilical vein endothelial cells (HUVEC) and human aortic smooth muscle cells (HASMC). AGTR1 or AGTR2 mRNA expression were undetectable in HUVEC, whereas HASMC expressed only AGTR1 mRNA. In summary, contrary to previous studies and the observed effects of LPS, we could not demonstrate direct vascular pro-inflammatory effects of Ang II ex vivo or in vitro. As indicated by our results, down-regulation or desensitization of AT1 R during culture may explain our findings. This article is protected by copyright. All rights reserved.

U2 - 10.1111/bcpt.12697

DO - 10.1111/bcpt.12697

M3 - Journal article

C2 - 27813367

VL - 120

SP - 335

EP - 347

JO - Basic & Clinical Pharmacology & Toxicology

JF - Basic & Clinical Pharmacology & Toxicology

SN - 1742-7835

IS - 4

ER -

ID: 168824683